Literature DB >> 22342270

Canadian Cardiovascular Society focused position statement update on assessment of the cardiac patient for fitness to drive: fitness following left ventricular assist device implantation.

Roger Baskett1, Richard Crowell, Darren Freed, Nadia Giannetti, Christopher S Simpson.   

Abstract

There have been significant advances in mechanical circulatory support during the past several years. Older pulsatile models of left ventricular assist devices (LVADs) (also known as VADs) have shown improved outcomes compared with medical therapy but have had limited durability and significant morbidity associated with their use. For this reason, Canadian Cardiovascular Society 2003 guidelines recommended permanent cessation of driving in these patients (for both private and commercial vehicle operation). However, recent advances with newer, continuous-flow devices have resulted in much lower rates of device-related complications and greater use of these devices for destination therapy. The majority of patients now are discharged home and lead active lives subsequently. Based on new evidence applied to the Society's "Risk of Harm" formula, it has been determined that patients with continuous-flow devices who are doing well 2 months post implantation are fit to hold noncommercial class drivers' licenses. Copyright Â
© 2012 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22342270     DOI: 10.1016/j.cjca.2011.11.017

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  2 in total

1.  Assessing fitness to drive in brain tumour patients: a grey matter of law, ethics, and medicine.

Authors:  A V Louie; E Chan; M Hanna; G S Bauman; B J Fisher; D A Palma; G B Rodrigues; A Warner; D P D'Souza
Journal:  Curr Oncol       Date:  2013-04       Impact factor: 3.677

2.  2019 EACTS Expert Consensus on long-term mechanical circulatory support.

Authors:  Evgenij V Potapov; Christiaan Antonides; Maria G Crespo-Leiro; Alain Combes; Gloria Färber; Margaret M Hannan; Marian Kukucka; Nicolaas de Jonge; Antonio Loforte; Lars H Lund; Paul Mohacsi; Michiel Morshuis; Ivan Netuka; Mustafa Özbaran; Federico Pappalardo; Anna Mara Scandroglio; Martin Schweiger; Steven Tsui; Daniel Zimpfer; Finn Gustafsson
Journal:  Eur J Cardiothorac Surg       Date:  2019-08-01       Impact factor: 4.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.